BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Metabolism of nitric oxide
,
Prozac
,
rs7903146
,
CXCL2
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Triton X-100
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Glioblastoma C419 cells from patient-derived xenograft tumors treated with mithramycin
Embryonic kidney HEK293T17 cells with SUZ12 knockdown for 48hr
Brain mRNA of E18 embryos after co-immunoprecipitation with an anti-Stau2 antibody
mRNAs associated with human DAZ-interacting protein (DZIP1) in HeLa cells
Diffuse large B cell lymphoma SUDHL-2 and SUDHL-4 cells with mTOR inhibition by ethanol or INK128
Explore Curated Studies Results
Literature
Most Relevant Literature
SDBS-AEO Mixture for Triton X-100 Replacement: Surface Activity and Application in Biosensors.
Mechanisms of Triton X-100 reducing the Ag+-resistance of Enterococcus faecalis.
Triton X-100 counteracts antibiotic resistance of Enterococcus faecalis: An in vitro study.
Triton X-100 enhanced antibacterial effect of photodynamic therapy against Enterococcus faecalis inf…
Unraveling the Biophysical Mechanisms of How Antiviral Detergents Disrupt Supported Lipid Membranes:…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)
Reducing the Burden of Influenza After Solid-Organ Transplantation
Comparison of 4 Influenza Vaccines in Seniors
The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT n…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ